Condition
Pervasive Developmental Disorders
Total Trials
3
Recruiting
0
Active
0
Completed
3
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 3 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
33%
1 of 3 completed with results
Key Signals
1 with results100% success
Data Visualizations
Phase Distribution
2Total
Not Applicable (2)
Trial Status
Completed3
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (3)
Showing 3 of 3 trials
NCT01931033Not ApplicableCompleted
An Open-Label Trial of Oxytocin in Adolescents With Autism Spectrum Disorders
NCT01430845Completed
Predicting Developmental Disability Type and Mental Retardation Level in Children With General Developmental Delay
NCT02147236Not ApplicableCompletedPrimary
Social Skills in Children With Autism Spectrum Disorders
Showing all 3 trials